NCT04322864

Brief Summary

Introduction: Shoulder pain is a condition of high prevalence in the general population. Studies indicate that physiotherapeutic treatment with exercise is effective in reducing pain and restoring function in patients with shoulder pain. Patients may have difficulty accessing the physiotherapy service due to the cost of treatment, transportation to the service, and long waiting lines. A possible solution is the use of a telerehabiliation intervention to increase access to physiotherapy for shoulder pain patients. Objective: To assess the effectiveness of telerehabilitation when compared to in-person physiotherapy on pain and disability in individuals with persistent rotator cuff related shoulder pain. Methods: This study is a controlled, randomized, blinded clinical trial. A total of 184 individuals with shoulder pain were randomly assigned to two groups. One group received a telerehabiliation intervention and the other group received the in-person intervention. The intervention consisted of strengthening exercises with emphasis on the lateral rotator and scapulothoracic muscles. The primary outcome was pain and disability (SPADI, Shoulder Pain and Disability Index), and the secondary outcomes were pain intensity (NPRS, Numerical Pain Rating Scale), function (DASH questionnaire, Disabilities of the Arm, Shoulder and Hand), self-efficacy (CPSS, Chronic Pain Self-Efficacy Scale), kinesiophobia (Cover Scale), patient expectation of treatment (7-point Likert Scale), and patient self-perceived improvement (Global Change Assessment Scale). All outcomes were measured before and after 12 weeks of treatment (2x/week). Normality of data was verified by Kolmogorov Smirnov's test. Differences between groups were assessed using the mixed linear models including the group × time interaction. The effect size was calculated for the variables between the groups. The significance level was set at 5%.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
184

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 26, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

3 years

First QC Date

March 23, 2020

Last Update Submit

July 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in baseline Shoulder Pain and Disability to 12 weeks

    Shoulder Pain and Disability will be measured with Shoulder Pain and Disability Index with scores ranging from 0 to 100 (higher score reflects higher pain and disability)

    Pre (baseline) treatment, post treatment (12 weeks)

Secondary Outcomes (6)

  • Change in baseline Pain to 12 weeks

    Pre (baseline) treatment, post treatment (12 weeks)

  • Change in baseline Function to 12 weeks

    Pre (baseline) treatment, post treatment (12 weeks)

  • Change in baseline Self-efficacy to 12 weeks

    Pre (baseline) treatment, post treatment (12 weeks)

  • Change in baseline Kinesiophobia to 12 weeks

    Pre (baseline) treatment, post treatment (12 weeks)

  • Patients' expectation with the treatment at baseline

    Pre (baseline) treatment

  • +1 more secondary outcomes

Study Arms (2)

In-person supervised intervention

ACTIVE COMPARATOR
Other: Therapeutic exercises

Web-based instrument intervention

EXPERIMENTAL
Other: Therapeutic exercises

Interventions

Patients will perform strengthening exercises focusing on scapulothoracic muscles and shoulder lateral rotators.

In-person supervised interventionWeb-based instrument intervention

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-60;
  • Self-reported pain of intensity equal to or greater than 3 points on the numerical pain scale (NDT) at rest or arm movement in the anterolateral region of the shoulder;
  • Duration of at least 3 months of shoulder pain;

You may not qualify if:

  • History of trauma related to the onset of symptoms;
  • History of clavicle, scapula or humerus fracture;
  • History of surgical stabilization or rotator cuff repair;
  • History of shoulder dislocation;
  • Pain related to the cervical spine;
  • Adhesive capsulitis;
  • Systemic disease involving the joints and cognitive alteration that makes it impossible to carry out questionnaires or use the mobile application.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal de São Carlos

São Carlos, São Paulo, 13565-905, Brazil

Location

MeSH Terms

Conditions

Shoulder PainMusculoskeletal Diseases

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 23, 2020

First Posted

March 26, 2020

Study Start

October 1, 2021

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

August 3, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

At the end of the clinical trial will be published the Study Protocol and Statistical Analysis Plan (SAP), if any researcher wants more information can request. The Informed Consent Form (ICF) can also be available.

Locations